Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
Sponsor: Institut Paoli-Calmettes
Summary
Pancreatic cancer is among the most serious human neoplasia and the most difficult to treat. Most patients present at diagnosis a non resectable, locally advanced or metastatic disease, with a median survival of 12 month. The aim of this study is the identification of diagnosis biomarkers, predictive of the therapeutic response. This project investigate the use of molecular analyses applied to pancreatic tumor cells collected by microbiopsy under ultrasound-endoscopy, and blood cells.
Official title: Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
274
Start Date
2012-02
Completion Date
2017-12
Last Updated
2026-04-21
Healthy Volunteers
No
Conditions
Interventions
suspected pancreatic tumor
Realization of pancreatic surgery to obtain tumor biopsy and blood samples to realize biomarkers analyses.
Locations (1)
Marine GILABERT, MD
Marseille, France